Plasma Rivaroxaban Level in Patients With Early Stages of Chronic Kidney Disease-Relationships With Renal Function and Clinical Events
Introduction Drug accumulation of rivaroxaban is a concern in patients with chronic kidney disease (CKD). Data regarding the plasma rivaroxaban levels in early CKD patients and its relationship with clinical events is lacking. Methods Early CKD patients (Stage 1-3) with atrial fibrillation who recei...
Saved in:
Main Authors: | Chun-Fung Sin (Author), Ka-Ping Wong (Author), Hoi-Man Wong (Author), Chung-Wah Siu (Author), Desmond Y. H. Yap (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Plasma apixaban levels in Chinese patients with chronic kidney disease-Relationship with renal function and bleeding complications
by: Chun-fung Sin, et al.
Published: (2022) -
Unraveling genetic contributors to bleeding events induced by rivaroxaban treatment
by: Yongping Chen, et al.
Published: (2023) -
Pharmacogenetics and pharmacokinetics of rivaroxaban in patients with atrial fibrillation and chronic kidney disease
by: N. A. Shatalova, et al.
Published: (2023) -
Risk Factors for Rivaroxaban-Related Bleeding Events-Possible Role of Pharmacogenetics: Case Series
by: Livija Šimičević, et al.
Published: (2023) -
THE ADVANCED TACTICS OF THE MANAGEMENT OF PATIENTS WITH VENOUS THROMBOEMBOLISM: THE ROLE OF RIVAROXABAN AT VARIOUS STAGES OF TREATMENT
by: S. R. Gilyarevskiy
Published: (2016)